Sichuan Kelun Pharmaceutical Co Ltd (szse:002422) Share Price

Company Profile

Business description
Sichuan Kelun Pharmaceutical Co Ltd is a China-based pharmaceutical company focused on the manufacturing of infusion products, antibiotics, and various medical devices. The company operates its businesses through three segments. The Twinings segment focuses on producing pharmaceutical intermediates. The Botai segment is dedicated to the research, development, manufacturing, and commercialization of medicines. The Other Business segment covers activities such as the development and production of large-volume injections, along with the research, manufacturing, and sales of additional pharmaceutical products and related businesses.
Contact
No. 36, Baihua West Road
Qingyang District
Chengdu610071
CHN
T: +86 2882860516
https://www.kelun.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2026
Employees
20,127

Recommended

We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.

Brian Colello, CPA | 23 July 2026

A closer look at the stocks and ETFs that captured Aussie investors’ attention in FY26.

Tyger Fitzpatrick | 23 July 2026

Where value remains in Australian banks.

Tyger Fitzpatrick | 23 July 2026

Index	Last price	Change	% Change
All Ordinaries	9,018.10	41.40	-0.46%
CAC 40	8,306.33	131.56	-1.56%
DAX 40	24,850.46	304.95	-1.21%
Dow JONES (US)	51,735.08	483.50	-0.93%
FTSE 100	10,650.83	66.14	-0.62%
HKSE	25,210.81	318.15	1.28%
NASDAQ	25,249.55	441.35	-1.72%
Nikkei 225	66,422.60	307.00	0.46%
NZX 50 Index	13,795.31	32.13	0.23%
S&P 500	7,429.43	69.53	-0.93%
S&P/ASX 200	8,839.00	38.60	-0.43%
SSE Composite Index	3,876.78	9.74	0.25%